SCHEMBL8319980

SCHEMBL8319980

CC1=NS(=O)(=O)Nc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.44
PDE7B Q9NP56 1/20 0.44
CA12 O43570 4/20 0.41
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 4/20 0.41
KDM4E B2RXH2 5/20 0.40
HSD17B10 Q99714 3/20 0.40
ALDH1A1 P00352 3/20 0.40
RECQL P46063 2/20 0.40
LMNA P02545 3/20 0.33
CA4 P22748 2/20 0.33
CA7 P43166 2/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1622053 0.77 NOS2 (0.47) PDE7APDE7BCA12CA1CA2
SCHEMBL2291842 0.77 PDE7A (0.44) PDE7APDE7BCA12CA1CA2
SCHEMBL19152711 0.73 CA12 (0.34) CA12CA1CA2CA9KDM4E
SCHEMBL8490538 0.70 MAPT (0.38) PDE7APDE7BKDM4EHSD17B10ALDH1A1
SCHEMBL12323422 0.69 CA12 (0.32) CA12CA1CA2CA9
SCHEMBL2417957 0.68 KDM4E (0.46) CA12CA1CA2CA9KDM4E
SCHEMBL9643692 0.68 PDE7A (0.75) PDE7APDE7BCA12CA1CA2
SCHEMBL1621965 0.66 NOS2 (0.40) CA12CA1CA2CA9ALDH1A1
SCHEMBL652970 0.65 PKM (0.53) CA12CA1CA2CA9HSD17B10
SCHEMBL12322083 0.65 MAP4K4 (0.36) PDE7APDE7BHSD17B10ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929072-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ELI LILLY AND COMPANY LIMITED (GB) 1999-07-27 US disclosed
EP-0897921-A1 Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands ELI LILLY AND COMPANY LIMITED (GB) 1999-02-24 EP disclosed
EP-0549666-B1 NOVEL AMINOBENZOSULTAM DERIVATIVES AS LIPOXYGENASE INHIBITORS PFIZER (US) 1994-11-23 EP disclosed